Co-Authors
This is a "connection" page, showing publications co-authored by Linlin Bao and Qi Lv.
Connection Strength
3.134
-
Sensitivity of SARS-CoV-2 to different temperatures. Animal Model Exp Med. 2020 Dec; 3(4):316-318.
Score: 0.921
-
Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza. Signal Transduct Target Ther. 2021 05 20; 6(1):200.
Score: 0.237
-
Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats. J Infect Dis. 2021 04 23; 223(8):1313-1321.
Score: 0.235
-
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice. J Infect Dis. 2020 07 23; 222(4):551-555.
Score: 0.223
-
Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo. Signal Transduct Target Ther. 2020 05 08; 5(1):66.
Score: 0.220
-
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020 07; 583(7818):830-833.
Score: 0.220
-
Diverse biological characteristics and varied virulence of H7N9 from Wave 5. Emerg Microbes Infect. 2019; 8(1):94-102.
Score: 0.201
-
ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques. Cell Mol Immunol. 2021 05; 18(5):1308-1310.
Score: 0.059
-
Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2. Acta Pharm Sin B. 2021 Sep; 11(9):2850-2858.
Score: 0.058
-
SARS-CoV-2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice. Animal Model Exp Med. 2021 03; 4(1):2-15.
Score: 0.058
-
Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2021 Feb; 590(7844):E23.
Score: 0.058
-
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy. Cell. 2020 11 12; 183(4):1013-1023.e13.
Score: 0.056
-
Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nat Commun. 2020 09 02; 11(1):4400.
Score: 0.056
-
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020 10; 586(7830):572-577.
Score: 0.056
-
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020 08 14; 369(6505):818-823.
Score: 0.056
-
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. Cell. 2020 07 09; 182(1):73-84.e16.
Score: 0.055
-
Age-related rhesus macaque models of COVID-19. Animal Model Exp Med. 2020 Mar; 3(1):93-97.
Score: 0.055
-
Human-Derived A/Guangdong/Th005/2017 (H7N9) Exhibits Extremely High Replication in the Lungs of Ferrets and Is Highly Pathogenic in Chickens. Viruses. 2019 05 29; 11(6).
Score: 0.052
-
Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLoS Pathog. 2018 11; 14(11):e1007428.
Score: 0.050
-
Neurotropism In Vitro and Mouse Models of Severe and Mild Infection with Clinical Strains of Enterovirus 71. Viruses. 2017 11 20; 9(11).
Score: 0.046
-
V?4+?dT Cells Aggravate Severe H1N1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury via Secreting Interleukin-17A. Front Immunol. 2017; 8:1054.
Score: 0.046
-
Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset. J Infect Dis. 2017 06 15; 215(12):1807-1815.
Score: 0.045
-
Intranasal immunization of mice with inactivated virus and mast cell activator C48/80 elicits protective immunity against influenza H1 but not H5. Immunol Invest. 2014; 43(3):224-35.
Score: 0.035
-
An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J Infect Dis. 2014 Jan 15; 209(2):236-42.
Score: 0.035